Can TCF7L2 help with Müdigkeit?

TCF7L2 is a transcription factor strongly associated with type 2 diabetes risk (GWAS, rs7903146). There is no direct evidence that it helps with fatigue. However, fatigue can be a symptom of undiagnosed or poorly controlled diabetes. A TCF7L2 risk variant from a consumer DNA test is not a diagnostic tool but an indicator of increased diabetes risk. The evidence for the diabetes association is strong (human-strong), but the link to fatigue is indirect and mechanistically plausible, not clinically confirmed. Lifestyle interventions (diet, exercise, weight management) can reduce diabetes risk and may thereby alleviate fatigue-related symptoms. A genetic test alone does not help with fatigue; persistent exhaustion requires medical evaluation (blood glucose, thyroid, iron status, etc.). Marketing claims that TCF7L2 is an 'energy gene' are misleading. The evidence level here is 'gwas' for the diabetes association, but for the specific question about fatigue, it is indirect and should not be overinterpreted.